TXSE foreign private issuer listings: when the new alternative makes sense.
The Texas Stock Exchange received SEC approval on September 30, 2025. The exchange began live trading on July 10, 2026, and first corporate listings are scheduled for early October 2026. For foreign private issuers, Rule 16.312 provides an alternative pathway, four financial tests, recognizable distribution standards, and meaningful home country practice accommodation. Here is what it requires, when it makes sense, and when it does not.
Status as of September 28, 2026. The Texas Stock Exchange, approved by the SEC on September 30, 2025, began live trading on July 10, 2026 and listed its first exchange-traded products on September 16, 2026. Corporate listing transfers are scheduled to begin in early October 2026, with Energy Transfer and Dillard's among the companies set to begin trading on the exchange on October 5. The Rule 16.312 standards discussed below reflect the TXSE rulebook as updated February 20, 2026.
The Texas Stock Exchange received SEC approval to operate as a registered national securities exchange under Section 6 of the Exchange Act on September 30, 2025, the first new fully integrated U.S. exchange, for both listings and trading, to receive such approval in decades. The exchange began live trading on July 10, 2026, listed its first exchange-traded products in September 2026, and has scheduled its first corporate listings for early October 2026.
For foreign private issuers, the TXSE has published a specific rule, Rule 16.312, that establishes alternative initial listing requirements separate from the domestic standards in Rule 16.310. The FPI framework matters because cross-border listing strategy has changed significantly in the past two years. The Texas Business Court is now operational. Senate Bill 29 has reshaped Texas corporate governance. A growing list of public companies has redomesticated to Texas from Delaware and other jurisdictions. The TXSE's emergence is a coherent next step in this broader Texas commercial law evolution.
What follows is what Rule 16.312 requires, when it makes strategic sense, and where the practical limits are. The analysis draws on the published TXSE rulebook, communications with TXSE personnel, and the underlying U.S.-Canada cross-border framework that governs much of the FPI population the rule is designed to attract.
What Rule 16.312 requires
A foreign private issuer seeking to list on the TXSE under Rule 16.312 must satisfy three categories of requirements: financial standards, distribution standards, and governance.
Financial standards, one of four tests
The TXSE accepts qualification under any one of four tests under Rule 16.312(b)(2). Each accommodates a different issuer profile.
The Earnings Test requires adjusted pre-tax earnings from continuing operations of at least $100 million in aggregate over the last three fiscal years, with at least $25 million in each of the two most recent fiscal years. This is the path for established profitable companies, typically larger Canadian energy companies, resource issuers with sustained earnings, and operating businesses with multi-year track records.
The Valuation/Revenue Test requires adjusted cash flows of $100 million in aggregate over the last three fiscal years, $25 million in each of the two most recent, plus $500 million in global market capitalization and $100 million in revenue during the most recent twelve-month period. This is the path for companies with strong cash generation and a meaningful equity market presence.
The Pure Valuation/Revenue Test drops the earnings and cash flow requirements but demands $750 million in global market capitalization and $75 million in revenue during the most recent fiscal year. This is the path for issuers whose value rests on equity market validation more than historical earnings, newer high-growth issuers, certain technology companies, and businesses where reported earnings understate underlying economics.
The Affiliated Company Test requires only $500 million in global market capitalization and twelve months of operating history, provided that an affiliated company is already listed and in good standing on a recognized exchange and either retains control of the listing entity or is under common control. This is the path most relevant for carve-outs and spin-offs from established public companies.
For practical purposes, most FPI candidates evaluate their options against either the Earnings Test (for established profitable issuers) or the Pure Valuation/Revenue Test (for issuers whose market capitalization is well-established but earnings are inconsistent).
Distribution standards
These are stricter than companies sometimes expect. Under Rule 16.312(b)(1), an FPI must demonstrate at least 5,000 round lot holders worldwide, at least 2.5 million publicly held shares, a market value of publicly held shares of at least $100 million for non-affiliated listings (reduced to $60 million for affiliate listings), and a minimum share price of $4.00.
The 5,000 round lot holder threshold is the constraint that matters most. Round lot holders are shareholders of record and beneficial holders of shares held in street name, ; shares held by directors, executive officers, their family members, and 10 percent or greater holders are excluded from the publicly held share count. For issuers with concentrated ownership, common among Canadian energy companies, family-controlled enterprises, and certain technology companies post-IPO, this can be a binding constraint. Pre-listing capital markets work, often including a secondary offering, may be required to broaden the holder base before the listing application can advance.
Board composition and governance
The TXSE requires a majority of independent directors on the board, an audit committee of at least three independent financially literate directors with one qualifying as a financial expert, and independence for each member of the compensation and nominating committees. The definitions of independence under Rule 16.405(a)(2) exclude directors with material relationships including employment in the past three years, compensation exceeding $120,000 in any twelve-month period, family relationships with executive officers, or audit-firm affiliations within the past three years.
These standards are recognizable to anyone who has worked on NYSE or NASDAQ listings, the substantive structure is similar to the business judgment rule framework familiar from broader corporate governance practice. The newly listed IPO phase-in periods are also familiar: twelve months to achieve a majority independent board, staggered committee phase-in with one independent member upon listing, majority within ninety days, full independence within one year.
The accommodation that distinguishes Rule 16.312 from the domestic standards is the home country practice reliance. A foreign private issuer may follow its home country corporate governance practice in lieu of TXSE Rule Series 16.400, subject to specific non-waivable requirements including the notification-of-noncompliance requirement, the voting rights requirement, and the audit committee requirements under Exchange Act Rule 10A-3(b)(1). This is the structural feature that makes the rule workable for Canadian issuers operating under National Instrument 51-102 and 58-101.
The FPI accommodation that matters most: home country practice
Rule 16.312 incorporates a meaningful accommodation for FPIs. A foreign private issuer may follow its home country corporate governance practice in lieu of TXSE Rule Series 16.400, in lieu of third-party director and nominee compensation disclosure under Rule 16.207(b)(3), and in lieu of the requirement to distribute annual and interim reports under Rule 16.207(d).
The conditions for relying on home country practice are non-trivial. The issuer must comply with the notification-of-noncompliance requirement under Rule 16.410, the voting rights requirement under Rule 16.413, and the audit committee requirements under Rule 16.405(c)(2), which incorporates Rule 10A-3(b)(1) of the Exchange Act. The issuer must also disclose its reliance on home country practice and describe the home country alternative.
For Canadian issuers, this matters substantially. Canadian governance practice operates under National Instrument 58-101 (Disclosure of Corporate Governance Practices), the disclosure obligations under National Instrument 51-102 (Continuous Disclosure Obligations), and the corporate governance regimes of the various provincial securities commissions. The TXSE home country practice framework is substantively similar to the analogous NYSE and NASDAQ accommodations for FPIs. The structural equivalence matters: a Canadian issuer that has been managing governance disclosure for a NYSE or NASDAQ listing has roughly similar overhead for TXSE listing.
The voting rights requirement under Rule 16.413 prohibits disparate reduction of existing shareholder voting rights, important for FPIs with dual-class structures who must monitor compliance carefully. The audit committee requirements track Exchange Act Rule 10A-3 and require an audit committee composed of independent directors with specific responsibilities for engagement of the registered public accounting firm. These are the substantive features the home country practice accommodation cannot waive.
The process and timeline
The path to TXSE listing follows a structured sequence. A company first engages with TXSE representatives and requests clearance to submit an initial listing application. TXSE Regulation conducts a free, confidential eligibility review, approximately two weeks, for which the company must provide a draft registration statement, historical financials, and director biographies. Upon completion, TXSE Regulation issues a clearance letter valid for nine months. The company then submits the full listing application, supporting documents, and any updated financials. TXSE Regulation provides final approval and authorization to list.
For an FPI considering a TXSE listing, expect a six- to nine-month engagement from initial discussion to first trade, including the SEC registration statement work, market-maker arrangements (the TXSE requires four market makers, with potential exceptions for three under Rule 16.312(c)), and the customary capital markets preparation. For dual listings of issuers already trading on the TSX, the timeline is typically shorter and can compress into four to six months with appropriate counsel coordination.
When does TXSE make strategic sense?
This is where the practical analysis matters. Based on the structure of Rule 16.312, the broader market shift toward Texas reflected in the Texas Redomesticators tracker, and cross-border listing decision patterns, four scenarios are worth evaluating.
Scenario one: dual listings for established TSX issuers seeking U.S. presence. For a Canadian issuer already listed on the TSX or TSXV that has decided U.S. investor access is strategically important, the TXSE provides a third option alongside NYSE and NASDAQ. The Texas Business Court forum, the Texas governance framework reshaped by SB 29, and the proximity to U.S. energy capital markets are tangible advantages for resource and energy issuers in particular. The cost structure, which TXSE has signaled will be designed to be more competitive than incumbent exchanges, may make the math work for issuers whose U.S. capital markets value justifies the listing but who have struggled with NYSE or NASDAQ economics.
Scenario two: primary listings by FPIs with Texas operational nexus. A foreign company with substantive Texas operations, energy infrastructure, real estate, manufacturing, may find that primary listing on the TXSE aligns more naturally with its operational footprint than a NYSE or NASDAQ listing. This is particularly true for FPIs anticipating Texas redomestication in the medium term, where TXSE primary listing pairs with eventual Texas incorporation as a coherent strategic move.
Scenario three: emerging growth companies prioritizing reporting efficiency. With the SEC having proposed in May 2026 amendments to allow optional semi-annual reporting, the cost structure of being a public company is in flux. For emerging growth companies particularly sensitive to reporting overhead, the TXSE signaled emphasis on innovation and lower public company costs is worth tracking.
Scenario four: structured listings tied to existing affiliates. The Affiliated Company Test creates a defined path for spin-offs and carve-outs from established public companies. For FPIs with structured corporate relationships where the affiliated company test fits, the TXSE provides a workable framework.
When it does not make sense
For FPIs not yet listed in the U.S. and with no specific reason to prefer Texas over other U.S. exchanges, NYSE and NASDAQ remain the default. The depth of analyst coverage, the breadth of institutional investor familiarity, the index inclusion mechanics, and the secondary market liquidity favor the established exchanges substantially for general-purpose U.S. listings. TXSE will need to build these network effects over time, and an early TXSE listing is a strategic bet on that network development.
For FPIs whose primary U.S. investor base is concentrated in financial services, healthcare, or technology sectors rather than energy and industrials, the existing exchange ecosystems may serve better. The TXSE natural strength will likely cluster around energy, industrials, real estate, and the Texas operational nexus, sectors where Texas corporate law jurisprudence and the Texas Business Court provide value alongside the listing itself.
For controlled companies subject to specific governance accommodations, the analysis should include careful review of how TXSE rules interact with the controlled company status. The TXSE provides exemptions for controlled companies under Rule 16.407(a)(7) that parallel NYSE and NASDAQ accommodations, but the specific application requires careful attention to fiduciary duty implications under the controlled company framework.
What to be watching for
Three developments will shape whether the TXSE becomes a meaningful third option for FPIs over the next eighteen months.
First, the rule amendments the TXSE has signaled. Communications from TXSE personnel to outside counsel have indicated that the exchange anticipates amendments to listing qualifications designed to provide innovation and to lower the cost of operating as a public company. The substance and timing of these amendments will matter materially for the economic case.
Second, the inaugural listings. The first announced corporate listings, transfers by Energy Transfer, Sunoco, USA Compression Partners, Texas Capital Bancshares, and Dillard's, will define the exchange's initial market positioning. If those listings cluster around Texas-domiciled energy and industrial issuers, the strategic case for FPIs in those sectors will be clearer. If the inaugural listings are more diversified, the proposition for a broader range of FPIs may emerge earlier than expected.
Third, the SEC broader posture on the new exchange. Approval was the threshold step, but ongoing interaction with the SEC on rule amendments, listing standard refinements, and operational matters will continue. The pace and substance of that interaction will influence how quickly the TXSE can compete effectively for FPI listings.
What to do now
For Canadian, European, and other foreign private issuers actively evaluating U.S. listing options or considering dual listings, the practical steps are short.
Step 1: Request the confidential eligibility review. The TXSE process begins with a free, non-binding review of whether the company meets initial listing criteria. It takes approximately two weeks and gives a clear answer on whether the financial and distribution standards work for the specific issuer.
Step 2: Evaluate the dual-listing case against your current exchange. If you are listed on the TSX or another non-U.S. exchange and are weighing U.S. listing options, TXSE deserves a seat at the table alongside NYSE and NASDAQ. The substantive analysis, investor base, sector fit, cost structure, governance overhead, will tell you whether it makes the short list.
Step 3: Monitor the rule amendments. The TXSE has signaled that initial rules will evolve. For issuers not in a hurry to list, watching the amendments over the coming months may yield a clearer picture before committing.
For companies in the right strategic position, the TXSE is a credible new option. For others, it remains an interesting market development that may matter more in 2027 and beyond. The honest answer for any specific issuer depends on the specific facts.
Bilateral counsel for cross-border listing strategy.
The TXSE's emergence creates a new variable in cross-border listing strategy, and the substantive analysis for any specific issuer is fact-specific. My cross-border practice covers Canadian companies evaluating U.S. listing options across NYSE, NASDAQ, and now TXSE; the dual-listing analysis where an existing TSX listing is the anchor; and the governance and disclosure overhead that comes with each pathway.
Bar admissions in Texas, Minnesota, and Alberta mean the analysis is integrated across both jurisdictions rather than translated between separate firms, particularly important when the home country practice accommodation is doing meaningful work in the listing application.
The first conversation is fifteen minutes. It tells you whether TXSE belongs on your short list, what the eligibility analysis looks like for your specific facts, and what the timeline and cost structure would be against your existing or planned U.S. listing options.
Going deeper on this topic? Brian Elliott and I covered the Texas Stock Exchange across two episodes of the Y'all Street Law Podcast, Episode 2: Equities in Dallas and Episode 8: Texas Stock Exchange. Together they trace the TXSE from initial announcement through SEC approval and toward its 2026 corporate listings launch.
Going deeper.
Questions I hear from Texas business owners and counsel on this topic.
When did the Texas Stock Exchange receive SEC approval?
The Texas Stock Exchange received SEC approval to operate as a registered national securities exchange under Section 6 of the Exchange Act on September 30, 2025. It was the first new fully integrated U.S. exchange, for both listings and trading, to receive such approval in decades. The exchange began live trading on July 10, 2026, and first corporate listings are scheduled for early October 2026.
What is the difference between TXSE Rule 16.310 and Rule 16.312?
Rule 16.310 establishes the domestic initial listing standards for U.S. companies. Rule 16.312 establishes alternative initial listing standards specifically for foreign private issuers. FPIs may elect to list under either rule. Rule 16.312 includes financial test variations designed for non-U.S. financial reporting frameworks and a substantive home country practice accommodation that permits FPIs to follow their home country corporate governance regime in lieu of TXSE Rule Series 16.400.
Which of the four financial tests is right for my company?
The Earnings Test fits established profitable companies with sustained earnings over multiple years. The Valuation/Revenue Test fits companies with strong cash generation and a $500M+ market capitalization. The Pure Valuation/Revenue Test fits issuers whose value rests on equity market validation, $750M market cap, $75M revenue, without requiring historical earnings. The Affiliated Company Test fits carve-outs and spin-offs tied to a parent or affiliate that is already listed on a recognized exchange. Most candidate FPIs evaluate against either the Earnings Test or the Pure Valuation/Revenue Test depending on profitability profile.
What is the home country practice accommodation?
A foreign private issuer may follow its home country corporate governance practice in lieu of TXSE Rule Series 16.400, in lieu of third-party director and nominee compensation disclosure under Rule 16.207(b)(3), and in lieu of the annual and interim report distribution requirement under Rule 16.207(d). The accommodation is conditioned on continued compliance with the notification of noncompliance requirement, the voting rights requirement, and the audit committee requirements under Exchange Act Rule 10A-3. The FPI must disclose its reliance and describe the home country alternative.
What is the 5,000 round lot holder threshold and why does it matter?
TXSE Rule 16.312(b)(1) requires at least 5,000 round lot holders worldwide for an FPI listing. Round lot holders are shareholders of record and beneficial holders of shares held in street name, ; shares held by directors, executive officers, their family members, and 10 percent or greater holders are excluded from the publicly held share count. For issuers with concentrated ownership, common among Canadian energy companies, family-controlled enterprises, and certain post-IPO technology companies, this is often a binding constraint. Pre-listing capital markets work to broaden the holder base may be required before the listing application can advance.
How long does the TXSE listing process take for a foreign private issuer?
For an FPI considering a TXSE listing, expect a six- to nine-month engagement from initial discussion to first trade. The TXSE confidential eligibility review takes approximately two weeks, followed by a clearance letter valid for nine months, followed by the full listing application and final approval. For dual listings of issuers already trading on the TSX, the timeline can compress to four to six months with appropriate counsel coordination.
Can I dual-list on TXSE alongside the TSX?
Yes. A Canadian issuer already listed on the TSX or TSXV can pursue a TXSE listing as a dual listing. This is one of the strategically clearest scenarios for TXSE: U.S. investor access is important, the Texas Business Court forum is a positive factor for governance-sensitive disputes, and the cost structure may be more competitive than NYSE or NASDAQ for issuers in energy, industrials, and Texas-nexus sectors.
When does TXSE listing NOT make sense for an FPI?
For FPIs not yet listed in the U.S. with no specific reason to prefer Texas, NYSE and NASDAQ remain the default, the depth of analyst coverage, institutional investor familiarity, and index inclusion mechanics favor the established exchanges. For FPIs whose primary U.S. investor base is concentrated in financial services, healthcare, or technology rather than energy and industrials, the existing exchange ecosystems may serve better. The TXSE strategic case is strongest where Texas operational nexus, sector fit, or dual-listing economics provide a specific reason to prefer Texas.
Defined terms.
The legal terminology in this article. Each term has a precise statutory or doctrinal definition in the Kraus Law glossary, with citations and Texas-specific application notes.
When the right U.S. exchange matters,
the analysis should be integrated.
Fifteen minutes is enough to identify whether TXSE belongs on your short list, what the eligibility analysis looks like, and how it compares against your existing or planned U.S. listing options.
This article is general information based on publicly available sources as of the publication date and is not legal advice for any specific situation. Outcomes depend significantly on the specific facts, entity structure, and timing involved. IRS guidance, regulatory positions, and case law continue to develop. Consult qualified legal counsel before making decisions that affect your specific situation. Chuck Kraus is licensed in Texas, Minnesota, and Alberta.